Jeong Hae Woong, Seung Won-Bae
Department of Diagnostic Radiology, Busan Baik Hospital, Inje University, Busan, Korea.
Department of Neurosurgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
J Cerebrovasc Endovasc Neurosurg. 2015 Dec;17(4):301-12. doi: 10.7461/jcen.2015.17.4.301. Epub 2015 Dec 31.
This retrospective study presents our experience with respect to the clinical and angiographic outcomes of patients treated with stent-assisted coil embolization using Solitaire™ AB stents.
From March 2011 to December 2014, 50 patients with 55 wide-necked and/or complex intracranial aneurysms were evaluated. Four patients presented with an acute subarachnoid hemorrhage. Stent deployment was performed with a standard coiling procedure in 49 aneurysms. Three patients underwent bailout stenting, 2 patients were treated by temporary stenting and one patient was treated only by stenting without coiling for dissecting aneurysm.
Successful placement of the Solitaire AB stent was achieved in all the cases. Based on the postprocedural angiographic results, a Raymond 1 was obtained in 32 (59%) of 54 aneurysms, excluded by one case of dissecting aneurysm, and a Raymond 2 in 13 (24%), and a Raymond 3 in 9 (17%). There was one thromboembolic (2%) and three hemorrhagic complications (6%). However, procedure-related morbidity or mortality was not found. Annual follow-up angiographic results from the embolization were obtained in 40 (74.1%) of 54 cases. These results were represented as Raymond 1 in 27 (67.5%), class 2 in 9 (22.5%), and class 3 in 4 (10%) cases. Angiographic improvement associated with progressive thrombosis of the aneurysm was obtained in 10 aneurysms. Four aneurysms were recanalized without requiring additional treatment. In-stent stenosis was found in one aneurysm, but stent migration was not seen on follow-up angiography.
Stent-assisted coil embolization using the Solitaire AB stent for treating wide-necked and/or complex intracranial aneurysms was found to be safe and effective immediately post-embolization and after follow-up. Long-term follow-up will be required to identify the effect of the Solitaire AB stent on recanalization rates.
本回顾性研究介绍了我们使用Solitaire™ AB支架进行支架辅助弹簧圈栓塞治疗患者的临床和血管造影结果。
2011年3月至2014年12月,对50例患有55个宽颈和/或复杂颅内动脉瘤的患者进行了评估。4例患者出现急性蛛网膜下腔出血。49个动脉瘤采用标准弹簧圈栓塞程序进行支架置入。3例患者接受补救性支架置入,2例患者接受临时支架置入治疗,1例夹层动脉瘤患者仅接受支架置入而未进行弹簧圈栓塞治疗。
所有病例均成功置入Solitaire AB支架。根据术后血管造影结果,54个动脉瘤(排除1例夹层动脉瘤)中32个(59%)达到Raymond 1级,13个(24%)达到Raymond 2级,9个(17%)达到Raymond 3级。有1例血栓栓塞并发症(2%)和3例出血并发症(6%)。然而,未发现与手术相关的发病率或死亡率。54例中有40例(74.1%)获得了栓塞术后的年度随访血管造影结果。这些结果显示为27例(67.5%)Raymond 1级,9例(22.5%)2级,4例(10%)3级。10个动脉瘤出现与动脉瘤逐渐血栓形成相关的血管造影改善。4个动脉瘤再通,无需额外治疗。在1个动脉瘤中发现支架内狭窄,但随访血管造影未发现支架移位。
使用Solitaire AB支架进行支架辅助弹簧圈栓塞治疗宽颈和/或复杂颅内动脉瘤在栓塞后即刻及随访后均被发现是安全有效的。需要长期随访以确定Solitaire AB支架对再通率的影响。